Delivery Order SPE2DB20D3104-SPE2DB22FV8P6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 26, 2023. The $1,672.66 firm fixed-price delivery order is for the supply of 60 units of the drug Lubiprostone 24 MCG Capsule. The contract has a performance period through May 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $1,675.74 for the supply of Lubiprostone 24 MCG Capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $235,150.92 for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a period of performance through January 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The U.S. government awarded a delivery order contract worth $2,776.48 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide pharmaceutical and medical supply products. The contract, which has a completion date of May 18, 2023, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,761.15 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. The IDC, which runs through November 2026, enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $228,635.07 firm-fixed-price delivery order is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of March 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV8P6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsule 60S, a pharmaceutical product. The $3,999.85 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 5, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC contract. There is no set-aside designation indicated for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/4/22 |